Skip to Content

Oseni

In the US, Oseni (alogliptin/pioglitazone systemic) is a member of the drug class antidiabetic combinations and is used to treat Diabetes, Type 2.

US matches:

Ingredient matches for Oseni

Alogliptin

Alogliptin is reported as an ingredient of Oseni in the following countries:

  • Hong Kong

Alogliptin benzoate (a derivative of Alogliptin) is reported as an ingredient of Oseni in the following countries:

  • United States

Pioglitazone

Pioglitazone is reported as an ingredient of Oseni in the following countries:

  • Hong Kong

Pioglitazone hydrochloride (a derivative of Pioglitazone) is reported as an ingredient of Oseni in the following countries:

  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide